AT320152B - Verfahren zur Herstellung von neuen Penicillinen - Google Patents

Verfahren zur Herstellung von neuen Penicillinen

Info

Publication number
AT320152B
AT320152B AT901072A AT901072A AT320152B AT 320152 B AT320152 B AT 320152B AT 901072 A AT901072 A AT 901072A AT 901072 A AT901072 A AT 901072A AT 320152 B AT320152 B AT 320152B
Authority
AT
Austria
Prior art keywords
production
new penicillins
penicillins
new
Prior art date
Application number
AT901072A
Other languages
German (de)
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of AT320152B publication Critical patent/AT320152B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10Oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06Anabolic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • C07D233/38One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
AT901072A 1971-10-23 1972-10-20 Verfahren zur Herstellung von neuen Penicillinen AT320152B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2152967A DE2152967C3 (de) 1971-10-23 1971-10-23 Acylureidopenicilline

Publications (1)

Publication Number Publication Date
AT320152B true AT320152B (de) 1975-01-27

Family

ID=5823251

Family Applications (1)

Application Number Title Priority Date Filing Date
AT901072A AT320152B (de) 1971-10-23 1972-10-20 Verfahren zur Herstellung von neuen Penicillinen

Country Status (31)

Country Link
JP (2) JPS57843B2 (tr)
AR (1) AR195805A1 (tr)
AT (1) AT320152B (tr)
BE (1) BE790440A (tr)
BG (2) BG20813A3 (tr)
CA (1) CA1019323A (tr)
CH (1) CH579089A5 (tr)
CS (1) CS188883B2 (tr)
CY (1) CY947A (tr)
DD (1) DD106044B3 (tr)
DE (1) DE2152967C3 (tr)
DK (1) DK134992C (tr)
EG (1) EG10826A (tr)
ES (1) ES407851A1 (tr)
FI (1) FI56839C (tr)
FR (1) FR2157908B1 (tr)
GB (1) GB1392849A (tr)
HK (1) HK18578A (tr)
HU (1) HU167986B (tr)
IE (1) IE37123B1 (tr)
IL (1) IL40628A (tr)
KE (1) KE2824A (tr)
LU (1) LU66332A1 (tr)
NO (1) NO143909C (tr)
PH (1) PH9893A (tr)
PL (2) PL89056B1 (tr)
RO (2) RO60670A (tr)
SE (1) SE412236B (tr)
SU (1) SU527139A3 (tr)
YU (1) YU264072A (tr)
ZA (1) ZA727473B (tr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL175419C (nl) * 1971-10-23 1984-11-01 Bayer Ag Werkwijze ter bereiding of vervaardiging van antibiotisch werkzame farmaceutische preparaten, alsmede werkwijze ter bereiding van antibiotisch werkzame alfa-gesubstitueerde 6-(alfa-(3-acylureido)acetylamino) penicillanzuurderivaten.
US3978056A (en) * 1971-10-23 1976-08-31 Bayer Aktiengesellschaft Penicillins
US3972870A (en) * 1971-10-23 1976-08-03 Bayer Aktiengesellschaft Penicillins
US3983105A (en) * 1971-10-23 1976-09-28 Bayer Aktiengesellschaft Penicillins
US3974142A (en) * 1971-10-23 1976-08-10 Bayer Aktiengesellschaft Penicillins
US4009272A (en) * 1971-10-23 1977-02-22 Bayer Aktiengesellschaft Penicillins
US3972869A (en) * 1971-10-23 1976-08-03 Bayer Aktiengesellschaft Penicillins
US3974141A (en) * 1971-10-23 1976-08-10 Bayer Aktiengesellschaft Penicillins
DE2258973A1 (de) * 1972-12-01 1974-06-06 Bayer Ag Penicilline, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS587637B2 (ja) * 1973-12-27 1983-02-10 住友化学工業株式会社 シンキペニシリンノ セイホウ
DE2407715C2 (de) * 1974-02-18 1982-12-02 Bayer Ag, 5090 Leverkusen Cephalosporine, Verfahren zu ihrer Herstellung sowie Arzneimittel
IL47168A (en) * 1974-05-09 1979-07-25 Toyama Chemical Co Ltd Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same
DE2525541C2 (de) * 1975-06-07 1984-01-12 Bayer Ag, 5090 Leverkusen β-Lactam-Antibiotica, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel
DE2810083A1 (de) 1978-03-08 1979-09-20 Bayer Ag Beta-lactam-verbindungen
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
EP1780213A1 (en) * 2005-10-27 2007-05-02 3M Innovative Properties Company Silicon-urea-azolides, their preparation and use in the preparation of silicones with isocyanate terminal groups
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
ATE516272T1 (de) 2007-09-14 2011-07-15 Ortho Mcneil Janssen Pharm 1,3-disubstituierte 4-(aryl-x-phenyl)-1h-pyridin- 2-one
DE602008004794D1 (de) 2007-09-14 2011-03-10 Addex Pharmaceuticals Sa 1',3'-disubstituierte 4-phenyl-3,4,5,6-tetrahydro-2h,1'h-ä1,4'übipyridinyl-2'-one
CA2698929C (en) 2007-09-14 2016-01-19 Addex Pharma S.A. 1,3-disubstituted-4-phenyl-1h-pyridin-2-ones
ES2637794T3 (es) 2007-11-14 2017-10-17 Janssen Pharmaceuticals, Inc. Derivados de imidazo[1,2-A]piridina y su uso como moduladores alostéricos positivos de receptores MGLUR2
BRPI0918055A2 (pt) 2008-09-02 2015-12-01 Addex Pharmaceuticals Sa derivados de 3-azabiciclo[3,1,0]hexila como moduladores de receptores metabotrópicos de glutamato.
CN102186477B (zh) 2008-10-16 2013-07-17 奥梅-杨森制药有限公司 作为代谢型谷氨酸受体调节剂的吲哚和苯并吗啉衍生物
CN102232074B (zh) 2008-11-28 2014-12-03 奥梅-杨森制药有限公司 作为代谢性谷氨酸盐受体调节剂的吲哚和苯并噁嗪衍生物
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
ES2409006T3 (es) 2009-05-12 2013-06-24 Janssen Pharmaceuticals Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de los receptores mGluR2
DK2430022T3 (da) 2009-05-12 2013-12-02 Janssen Pharmaceuticals Inc 1,2,4-Triazolo[4,3-a]pyridinderivater og deres anvendelse til behandlingen eller forebyggelse af neurologiske og psykiatriske lidelser
KR20120034721A (ko) * 2009-06-10 2012-04-12 테크필즈 바이오켐 코., 엘티디. 항균제 및 항균제-관련 화합물의 고투과 조성물 또는 전구약물
JP5852665B2 (ja) 2010-11-08 2016-02-03 ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド 1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
ES2552879T3 (es) 2010-11-08 2015-12-02 Janssen Pharmaceuticals, Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
AU2011328194B2 (en) 2010-11-08 2015-04-16 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
DK3096790T3 (da) 2014-01-21 2019-10-07 Janssen Pharmaceutica Nv Kombinationer omfattende positive allosteriske modulatorer eller orthosteriske agonister af metabotrop glutamaterg subtype 2-receptor og anvendelse af disse
KR20220039824A (ko) 2014-01-21 2022-03-29 얀센 파마슈티카 엔.브이. 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1770620A1 (de) * 1968-06-12 1971-11-11 Bayer Ag Neue Penicilline

Also Published As

Publication number Publication date
DD106044A5 (tr) 1974-05-20
HK18578A (en) 1978-04-14
DE2152967B2 (de) 1981-02-19
AU4806472A (en) 1974-04-26
CS188883B2 (en) 1979-03-30
NO143909C (no) 1981-05-06
JPS4849787A (tr) 1973-07-13
FI56839B (fi) 1979-12-31
HU167986B (tr) 1976-02-28
CH579089A5 (tr) 1976-08-31
IE37123B1 (en) 1977-05-11
DE2152967A1 (de) 1973-05-03
BG21609A3 (tr) 1976-07-20
IE37123L (en) 1973-04-23
JPS4849910A (tr) 1973-07-14
RO60670A (tr) 1976-10-15
CA1019323A (en) 1977-10-18
NO143909B (no) 1981-01-26
BG20813A3 (tr) 1975-12-20
DK134992C (da) 1977-07-18
BE790440A (tr) 1973-04-24
PL89056B1 (tr) 1976-10-30
IL40628A (en) 1976-08-31
PL93574B1 (tr) 1977-06-30
EG10826A (en) 1976-12-31
ES407851A1 (es) 1975-10-01
SU527139A3 (ru) 1976-08-30
JPS55391B2 (tr) 1980-01-08
FR2157908A1 (tr) 1973-06-08
YU264072A (en) 1982-06-18
PH9893A (en) 1976-06-08
LU66332A1 (tr) 1973-01-23
GB1392849A (en) 1975-04-30
DE2152967C3 (de) 1981-11-19
FR2157908B1 (tr) 1976-03-19
ZA727473B (en) 1973-07-25
RO63066A (fr) 1978-06-15
DK134992B (da) 1977-02-21
KE2824A (en) 1978-04-07
SE412236B (sv) 1980-02-25
DD106044B3 (de) 1990-07-18
IL40628A0 (en) 1972-12-29
JPS57843B2 (tr) 1982-01-08
FI56839C (fi) 1980-04-10
CY947A (en) 1978-06-23
AR195805A1 (es) 1973-11-09

Similar Documents

Publication Publication Date Title
AT320152B (de) Verfahren zur Herstellung von neuen Penicillinen
AT320637B (de) Verfahren zur Herstellung von neuen Imidazolderivaten
AT321462B (de) Verfahren zur Herstellung von neuen Penicillinen
AT318804B (de) Verfahren zur Herstellung von neuen 3-Methylencephalosporinen
AT314555B (de) Verfahren zur Herstellung von neuen Guanidinen
AT321460B (de) Verfahren zur Herstellung von Cephalosporinen
AT287198B (de) Verfahren zur Herstellung von neuen Penicillinen
AT308764B (de) Verfahren zur Herstellung von neuen N-Phosphonomethyl-acrylamiden
AT318140B (de) Verfahren zur Herstellung von neuen Penicillinen
AT327376B (de) Verfahren zur herstellung von neuen 7-acylamido-7-methoxy-cephemcarbonsaurederivaten
AT327377B (de) Verfahren zur herstellung von aminopenicillinen
CH553801A (de) Verfahren zur herstellung von neuen diazepinderivaten.
AT309683B (de) Verfahren zur Herstellung von neuen Penicillinen
AT323325B (de) Verfahren zur herstellung von neuen 3-oxyiminomethylcephalosporinverbindungen
AT312804B (de) Verfahren zur Herstellung von neuen Penicillinen
AT310187B (de) Verfahren zur Herstellung von neuen Phosphorverbindungen
AT289296B (de) Verfahren zur Herstellung von neuen Penicillinen
AT313299B (de) Verfahren zur Herstellung von neuen 2-Fluor-5-halogenphenylharnstoffen
AT323184B (de) Verfahren zur herstellung von neuen dibenzoxirenazepinderivaten
AT313915B (de) Verfahren zur Herstellung von neuen Guanidinomercaptocarbonsäuren
AT297223B (de) Verfahren zur Herstellung von neuen Penicillinen
AT329517B (de) Verfahren zur herstellung von chlorcyan
AT322736B (de) Verfahren zur herstellung von 3-carbomoyloxymethyl-cephalosporinen
AT296498B (de) Verfahren zur Herstellung von neuen Penicillinen
AT326269B (de) Verfahren zur herstellung von neuen halogenphenylthioacetamido-cephalosporinderivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee